NewAmsterdam Pharma Co NV (NAMS) PT Raised to $45 at Guggenheim

February 19, 2026 6:54 AM EST Send to a Friend
(Updated - February 19, 2026 7:55 AM EST)

Guggenheim analyst Debjit Chattopadhyay raised the price target on NewAmsterdam Pharma ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login